[Attempts to use gene therapy for reducing connective tissue disorders--osteogenesis imperfecta].
D000818:Animals; D003094:Collagen / Q000235:genetics / Q000378:metabolism; D024042:Collagen Type I / Q000235:genetics; D000090602:Collagen Type I, alpha 1 Chain; D004195:Disease Models, Animal; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D010013:Osteogenesis Imperfecta / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D016337:RNA, Catalytic / Q000627:therapeutic use
D024042:Collagen Type I; D000090602:Collagen Type I, alpha 1 Chain; D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic; C427204:hammerhead ribozyme; D003094:Collagen